Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology

Vista senzilla d'ítem
dc.contributor.authorGrazia, Giuseppe Di
dc.contributor.authorSchettini, Francesco
dc.contributor.authorSánchez Bayona, Rodrigo
dc.contributor.authorCasals Pascual, Climent
dc.contributor.authorPascual, Tomás
dc.contributor.authorGenerali, Daniele
dc.contributor.authorGennari, Alessandra
dc.contributor.authorVigneri, Paolo
dc.contributor.authorHarbeck, Nadia
dc.contributor.authorCortés, Javier
dc.contributor.authorPrat Aparicio, Aleix
dc.date.accessioned2026-04-29T17:29:52Z
dc.date.available2026-04-29T17:29:52Z
dc.date.issued2026-01-28
dc.date.updated2026-04-29T17:29:53Z
dc.description.abstractHormone receptor-positive/HER2-negative breast cancer evolves in response to therapy, demanding smarter, adaptive biomarker-based treatment strategies. We review emerging dynamic biomarkers to guide therapeutic decision-making, spanning tissue and liquid biopsies, metabolic imaging, and microbiome profiling, that capture tumor or host-related changes over time. By contrasting Academic and Industry approaches, we advocate for a cultural shift in clinical trial design and implementation, aiming to move from reactive to proactive Oncology.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec769784
dc.identifier.issn2374-4677
dc.identifier.pmid41605941
dc.identifier.urihttps://hdl.handle.net/2445/229253
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41523-026-00904-5
dc.relation.ispartofnpj Breast Cancer, 2026, vol. 12, 34
dc.relation.urihttps://doi.org/10.1038/s41523-026-00904-5
dc.rightscc-by (c) Giuseppe Di Grazia et al., 2026
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Fonaments Clínics)
dc.subject.classificationAssaigs clínics de medicaments
dc.subject.classificationCàncer de mama
dc.subject.classificationHormonoteràpia
dc.subject.otherDrug testing
dc.subject.otherBreast cancer
dc.subject.otherHormone therapy
dc.titleDynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
936415.pdf
Mida:
1000.06 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Fonaments Clínics)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (ISGlobal)